Thomas Mensink
Startup & Investment analyst @ Golden Egg Check
Amersfoort, The Netherlands
Thomas Mensink is a seed investor at Golden Egg Check in Amersfoort focused on Information Technology and Software. “The guy that knows everything about venture capital in the Netherlands”. It’s not true, but I aim to get close. In this way, I hope to contribute to a more transparent and professional startup ecosystem.Here’s what I do and enjoy most: - Investing in startups from our co-investment fund alongside great VCs and angels - Helping startups withtheir fundraising and getting them in touch with relevant investors - External scout & investment analyst for a number of Dutch VC funds and corporates - Periodic analyses and insights about the Dutch startup and venture capital landscape - Host of the At The Money podcast in which I discuss scaling and venture capital topics with founders and VCs - Arranging speeddates for selected startups/ scale-ups and venture capital investors in StartupRouletteYou can find my thoughts, analysis and podcasts on my personal blog (Startup Analyst), our Golden Egg Check blog, our monthly newsletter (GEC Insights) some leading Dutch tech/ startup websites and your favourite podcast app (search my name or 'At The Money').Want to get in touch with relevant investors or startups? Join StartupRoulette, our monthly online speeddate event for startups and investors, or request direct introductions with the investors that are active in your space. I take care of the matchmaking.
- Total investments:
- 6
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Thomas Mensink invests in
Stages Thomas Mensink invests in
Countries Thomas Mensink invests in
Investment Focus
Industry
- Information Technology 3 (50%)
- Software 2 (33%)
- Machine Learning 2 (33%)
- Genetics 1 (17%)
- Health Care 1 (17%)
Stage
- Seed 3 (50%)
- Pre-Seed 3 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
Orq.ai enables companies to integrate and operate their products using the power of Large Language Models through a single collaboration platform. The platform centralizes prompt management, streamlined experimentation, feedback collection, and real-time insight into performance and costs. It's compatible with all major Large Language Modelproviders, ensuring transparency and scalability in LLM Ops, ultimately leading to shorter customer release cycles and reduced costs for both experiments and production environments.For more information, please visit https://orq.ai | $5.8M / Seed / Dec 03, 2025 | |
|
|
The only crypto platform where you actually own your digital assets. Crypto custody, asset management and market access-as-a-service. | $2.3M / Seed / May 22, 2025 | |
|
|
We support small businesses on their decarbonization journey with expertise and financing. Reach Net Zero. For real. | $3.4M / Seed / Apr 15, 2025 | |
|
|
iki.ai is a knowledge interface for professionals & teams to stare and query or reason upon any data - webpages, YouTube videos, GitHub repos, pdfs, etc iki is by design searchable, self organising and has an LLM powered co-pilot to reason upon your data. We have a platform developed both for professionals and teams / SMBs. Now iki is aweb service with SaaS model, but we are planning to launch native apps. | Pre-Seed / Sep 25, 2024 | |
|
|
Orq.ai enables companies to integrate and operate their products using the power of Large Language Models through a single collaboration platform. The platform centralizes prompt management, streamlined experimentation, feedback collection, and real-time insight into performance and costs. It's compatible with all major Large Language Modelproviders, ensuring transparency and scalability in LLM Ops, ultimately leading to shorter customer release cycles and reduced costs for both experiments and production environments.For more information, please visit https://orq.ai | $838.4K / Pre-Seed / Oct 02, 2023 | |
|
|
OASYS NOW is a platform dedicated to helping chronic patients find treatments more efficiently by connecting them with relevant clinical trials based on their unique health data.m ±13months to real-time, for CROs, Trial Sites, and Pharma. The platform uses advanced algorithms to match patients with appropriate clinical trials globally, enhancingthe chances for individuals to receive personalized treatment options. OASYS NOW prioritizes patient privacy, employing a privacy-by-design approach while leveraging large medical data to improve health outcomes. | $250K / Pre-Seed / May 03, 2023 |
Co-Investors
About Golden Egg Check
Golden Egg Check Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Thomas Mensink
Startup & Investment analyst
|
|||
3 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Thomas Mensink invest in?
Thomas Mensink invests primarily in Information Technology, Software and Machine Learning startups, most often at Seed and Pre-Seed stage. Most of the 6 investments tracked by Shizune back companies in The Netherlands. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Thomas Mensink last invest?
The most recent investment recorded for Thomas Mensink closed in Dec 2025. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!